Invasive Fungal Infections Completed Phase 3 Trials for Voriconazole (DB00582)

Also known as: Invasive Fungal Infection / Invasive Mycosis / Invasive Infection, Fungal / Infection, Invasive Fungal / Invasive Fungal Disease / Fungal Invasive Disease / Invasive fungal infection (disorder) / Systemic fungal infection NOS / Disseminated mycosis / Systemic mycosis / Systemic mycosis (disorder)

IndicationStatusPhase
DBCOND0030131 (Invasive Fungal Infections)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00893555Pharmacologic Optimization of VoriconazoleTreatment
NCT00412893Isavuconazole (BAL8557) for Primary Treatment of Invasive AspergillosisTreatment